Citations (182)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (33)
Christina Mueller, Timothy J Ness & Jarred W Younger. (2021) Low-Dose Dextromethorphan for the Treatment of Fibromyalgia Pain: Results from a Longitudinal, Single-Blind, Placebo-Controlled Pilot Trial. Journal of Pain Research 14, pages 189-200.
Read now
Read now
Koray Ayar, Burcu M. Ökmen, Lale Altan & Esra K. Öztürk. (2021) Central sensitization and its relationship with health profile in Behçet’s disease. Modern Rheumatology 31:2, pages 474-480.
Read now
Read now
Ashraf F Hanna, Bishoy Abraham, Andrew Hanna & Adam J Smith. (2017) Effects of intravenous ketamine in a patient with post-treatment Lyme disease syndrome. International Medical Case Reports Journal 10, pages 305-308.
Read now
Read now
Elżbieta Skorupska, Agata Bednarek & Włodzimierz Samborski. (2013) Tender Points and Trigger Points – Differences and Similarities. Journal of Musculoskeletal Pain 21:3, pages 269-275.
Read now
Read now
Mira Meeus, Jo Nijs, Linda Hermans, Dorien Goubert & Patrick Calders. (2013) The role of mitochondrial dysfunctions due to oxidative and nitrosative stress in the chronic pain or chronic fatigue syndromes and fibromyalgia patients: peripheral and central mechanisms as therapeutic targets?. Expert Opinion on Therapeutic Targets 17:9, pages 1081-1089.
Read now
Read now
Matthias F Seidel & Wolfgang Müller. (2011) Differential pharmacotherapy for subgroups of fibromyalgia patients with specific consideration of 5-HT3 receptor antagonists. Expert Opinion on Pharmacotherapy 12:9, pages 1381-1391.
Read now
Read now
Michael J Fischer, Eva-Maria Strasser & Renate J Scheibe. (2011) Going in deeper and deeper: signal transduction pathways in myofacial trigger points – A narrative review. International Musculoskeletal Medicine 33:2, pages 64-74.
Read now
Read now
Karl G. Henriksson. (2009) The Fibromyalgia Syndrome: Translating Science into Clinical Practice. Journal of Musculoskeletal Pain 17:2, pages 189-194.
Read now
Read now
Rinie Geenen, Johannes W.G. Jacobs & Johannes W.J. Bijlsma. (2009) A Psychoneuroendocrine Perspective on the Management of Fibromyalgia Syndrome. Journal of Musculoskeletal Pain 17:2, pages 178-188.
Read now
Read now
Roxanne Y. Walder & Kathleen A. Sluka. (2008) Centering on Central Mechanisms in the Development and Maintenance of Chronic Widespread Muscle Pain. Journal of Musculoskeletal Pain 16:1-2, pages 107-113.
Read now
Read now
Roland Staud. (2007) Treatment of fibromyalgia and its symptoms. Expert Opinion on Pharmacotherapy 8:11, pages 1629-1642.
Read now
Read now
Patrick B Wood, Andrew J Holman & Kim D Jones. (2007) Novel pharmacotherapy for fibromyalgia. Expert Opinion on Investigational Drugs 16:6, pages 829-841.
Read now
Read now
SamuelA. McLean, DavidA. Williams & DanielJ. Clauw. (2005) Fibromyalgia After Motor Vehicle Collision: Evidence and Implications. Traffic Injury Prevention 6:2, pages 97-104.
Read now
Read now
Robert M. Bennett. (2004) Three Years Later: Presidential Address to MYOPAIN '04. Journal of Musculoskeletal Pain 12:3-4, pages 1-12.
Read now
Read now
Robert M. Bennett. (2004) Fibromyalgia Review. Journal of Musculoskeletal Pain 12:2, pages 35-44.
Read now
Read now
Dawn A Marcus. (2003) Current trends in fibromyalgia research. Expert Opinion on Pharmacotherapy 4:10, pages 1687-1695.
Read now
Read now
Anil Kumar Jain, Bruce M. Carruthers, Marjorie I. van de Sande, Stephen R. Barron, C. C. Stuart Donaldson, James V. Dunne, Emerson Gingrich, Dan S. Heffez, Frances Y.-K. Leung, Daniel G. Malone, Thomas J. Romano, I. Jon Russell, David Saul & Donald G. Seibel. (2003) Fibromyalgia Syndrome: Canadian Clinical Working Case Definition, Diagnostic and Treatment Protocols–A Consensus Document. Journal of Musculoskeletal Pain 11:4, pages 3-107.
Read now
Read now
Sally Aspegren Kendall, Karl G. Henriksson, Ingrid Hurtig, Ragnhild Raak, Ann Bengtsson, Birgitta Sören, Lis-Karin Wahren & Björn Gerdle. (2003) Differences in Sensory Thresholds in the Skin of Women with Fibromyalgia Syndrome: A Comparison Between Ketamine Responders and Ketamine Non-Responders. Journal of Musculoskeletal Pain 11:2, pages 3-9.
Read now
Read now
Kim Lawson. (2002) Tricyclic antidepressants and fibromyalgia: what is the mechanism of action?. Expert Opinion on Investigational Drugs 11:10, pages 1437-1445.
Read now
Read now
Tomas Trygg, Gunnar Lundberg, Elisabeth Rosenlund, Toomas Timpka & Björn Gerdle. (2002) Personality Characteristics of Women with Fibromyalgia and of Women with Chronic Neck, Shoulder, or Low Back Complaints in Terms of Minnesota Multiphasic Personality Inventory and Defense Mechanism Technique Modified. Journal of Musculoskeletal Pain 10:3, pages 33-55.
Read now
Read now
I. Jon Russell. (2002) Fibromyalgia Syndrome Subgroups. Journal of Musculoskeletal Pain 10:3, pages 1-7.
Read now
Read now
Karl G. Henriksson. (2002) Is Fibromyalgia a Central Pain State?. Journal of Musculoskeletal Pain 10:1-2, pages 45-57.
Read now
Read now
Joaquim J. F. Soares & Giorgio Grossi. (2002) A Randomized, Controlled Comparison of Educational and Behavioural Interventions for Women with Fibromyalgia. Scandinavian Journal of Occupational Therapy 9:1, pages 35-45.
Read now
Read now
Siv Söderberg & Berit Lundman. (2001) TRANSITIONS EXPERIENCED BY WOMEN WITH FIBROMYALGIA. Health Care for Women International 22:7, pages 617-631.
Read now
Read now
J. Eisinger. (2001) Seven Steps to Fibromyalgia. Journal of Musculoskeletal Pain 9:3, pages 115-122.
Read now
Read now
RW Clarke. (2000) Synaptic mechanisms in nociception: emerging targets for centrally-acting analgesics. Emerging Therapeutic Targets 4:2, pages 173-189.
Read now
Read now
Margareta Sandberg, Thomas Lundeberg & Björn Gerdle. (1999) Manual Acupuncture in Fibromyalgia: A Long-Term Pilot Study. Journal of Musculoskeletal Pain 7:3, pages 39-58.
Read now
Read now
T. Graven-Nielsen, J. Sörensen, K. G. Henriksson, M. Bengtsson & L. Arendt-Nielsen. (1999) Central Hyperexcitability in Fibromyalgia. Journal of Musculoskeletal Pain 7:1-2, pages 261-271.
Read now
Read now
L. Arendt-Nielsen, T. Graven-Nielsen & P. Svensson. (1999) Assessment of Muscle Pain in Humans–Clinical and Experimental Aspects. Journal of Musculoskeletal Pain 7:1-2, pages 25-41.
Read now
Read now
Linda Slot Fenger-Grøn, Thomas Graven-Nielsen, Lars Arendt-Nielsen, Peter Svensson, Kristian Steengaard-Pedersen & Troels Staehelin Jensen. (1998) Muscular Sensibility Assessed by Electrical Stimulation and Mechanical Pressure. Journal of Musculoskeletal Pain 6:4, pages 33-44.
Read now
Read now
Lisa Ekselius, Ann Bengtsson & Lars von Knotting. (1998) Personality Traits as Determined by Means of the Karolinska Scales of Personality in Patients with Fibromyalgia. Journal of Musculoskeletal Pain 6:2, pages 35-49.
Read now
Read now
Daniel J. Wallace. (1997) The Fibromyalgia Syndrome. Annals of Medicine 29:1, pages 9-21.
Read now
Read now
S. Enestrbm, A. Bengtsson & T. Frddin. (1997) Dermal IgG Deposits and Increase of Mast Cells in Patients with Fibromyalgia - Relevant Findings or Epiphenomena?. Scandinavian Journal of Rheumatology 26:4, pages 308-313.
Read now
Read now
Articles from other publishers (149)
Teruaki Nasu, Riku Kainuma, Hiroki Ota, Kazue Mizumura & Toru Taguchi. (2023) Increased nociceptive behaviors and spinal c-Fos expression in the formalin test in a rat repeated cold stress model. Neuroscience Research.
Crossref
Crossref
NezarM B. Gargori, Hazem Alahwal, Charles-Herve Vacheron & FarouqMohammad A. Alam. (2023) Predictive factors of success and failure for intravenous ketamine therapy in patients suffering from chronic neuropathic pain. Saudi Journal of Anaesthesia 17:3, pages 340.
Crossref
Crossref
George Deng. 2023. Functional Illness of the Head and Neck. Functional Illness of the Head and Neck
75
83
.
Subbulakshmi Sundaram & Ashok Swaminathan Govindarajan. 2022. Ketamine Revisited - New Insights into NMDA Inhibitors. Ketamine Revisited - New Insights into NMDA Inhibitors.
Antony Salvati, Amélie Daveluy, Roxane Claverie, Ghada Miremont-Salamé, Joelle Micallef & Élisabeth Frauger. (2022) Utilisation de la kétamine chez les patients ambulatoires : que pouvons-nous apprendre des pratiques actuelles ?. Therapies 77:5, pages 571-580.
Crossref
Crossref
Jozélio Freire de Carvalho & Thelma L Skare. (2022) Lidocaine in fibromyalgia: A systematic review. World Journal of Psychiatry 12:4, pages 615-622.
Crossref
Crossref
Eric S. Schwenk, Basant Pradhan, Rohit Nalamasu, Lucas Stolle, Irving W. Wainer, Michael Cirullo, Alexander Olson, Joseph V. Pergolizzi, Marc C. Torjman & Eugene R. Viscusi. (2021) Ketamine in the Past, Present, and Future: Mechanisms, Metabolites, and Toxicity. Current Pain and Headache Reports 25:9.
Crossref
Crossref
V. Morel & G. Pickering. (2021) Kétamine et douleur chronique en France : de la théorie à la pratique. Douleur et Analgésie 34:1, pages 22-28.
Crossref
Crossref
B. Metayer, G. Cormier, J. Dimet, S. Varin, V. André, M. Caulier, Y.-M. Pluchon & C. Cozic. (2021) Prise en charge de la fibromyalgie par des perfusions de kétamine : étude observationnelle. Douleur et Analgésie 34:1, pages 53-59.
Crossref
Crossref
Janell Tully, Jai Won Jung, Anjana Patel, Alyson Tukan, Sameer Kandula, Allen Doan, Farnad Imani, Giustino Varrassi, Elyse M. Cornett, Alan David Kaye, Omar Viswanath & Ivan Urits. (2021) Utilization of Intravenous Lidocaine Infusion for the Treatment of Refractory Chronic Pain. Anesthesiology and Pain Medicine 10:6.
Crossref
Crossref
Emma Guymer & Geoffrey Littlejohn. 2021. Fibromyalgia Syndrome. Fibromyalgia Syndrome
33
52
.
Daniel J. Clauw & Roie Tzadok. 2021. Fibromyalgia Syndrome. Fibromyalgia Syndrome
183
192
.
Megan Millicker & Angela Starkweather. (2020) Intravenous Ketamine Use for Patients With Chronic Pain Conditions. Topics in Pain Management 36:4, pages 1-8.
Crossref
Crossref
Anushka Soni, Stephanie Santos-Paulo, Andrew Segerdahl, M Kassim Javaid, Rafael Pinedo-Villanueva & Irene Tracey. (2020) Hospitalization in fibromyalgia: a cohort-level observational study of in-patient procedures, costs and geographical variation in England. Rheumatology 59:8, pages 2074-2084.
Crossref
Crossref
Igor Wilderman, Olga Pugacheva, Vsevolod (Sev) Perelman, Michael C T Wansbrough, Yuri Voznyak & Lukasz Zolnierczyk. (2020) Repeated Intravenous Lidocaine Infusions for Patients with Fibromyalgia: Higher Doses of Lidocaine Have a Stronger and Longer-Lasting Effect on Pain Reduction. Pain Medicine 21:6, pages 1230-1239.
Crossref
Crossref
Bo Zhu, Xiayun Zhou, Qinghe Zhou, Haiyan Wang, Shougen Wang & Kaitao Luo. (2019) Intra-Venous Lidocaine to Relieve Neuropathic Pain: A Systematic Review and Meta-Analysis. Frontiers in Neurology 10.
Crossref
Crossref
Lovedeep Singh, Anudeep Kaur, Manpreet S. Bhatti & Rajbir Bhatti. (2019) Possible Molecular Mediators Involved and Mechanistic Insight into Fibromyalgia and Associated Co-morbidities. Neurochemical Research 44:7, pages 1517-1532.
Crossref
Crossref
Paul R. Hutson & Alaa Abd-Elsayed. 2019. Infusion Therapy. Infusion Therapy
1
16
.
Gisèle Pickering, Véronique Morel & Joelle Micallef. (2018) Kétamine et douleur chronique : une revue narrative de son efficacité et sécurité. Therapies 73:6, pages 529-539.
Crossref
Crossref
Shervin Farahmand, Hadid Hamrah, Mona Arbab, Mojtaba Sedaghat, Hamed Basir Ghafouri & Shahram Bagheri-Hariri. (2018) Pain management of acute limb trauma patients with intravenous lidocaine in emergency department. The American Journal of Emergency Medicine 36:7, pages 1231-1235.
Crossref
Crossref
Steven E. Harte, Richard E. Harris & Daniel J. Clauw. (2018) The neurobiology of central sensitization. Journal of Applied Biobehavioral Research 23:2.
Crossref
Crossref
Steven P. Cohen, Anuj Bhatia, Asokumar Buvanendran, Eric S. Schwenk, Ajay D. Wasan, Robert W. Hurley, Eugene R. Viscusi, Samer Narouze, Fred N. Davis, Elspeth C. Ritchie, Timothy R. Lubenow & William M. Hooten. (2018) Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists. Regional Anesthesia and Pain Medicine, pages 1.
Crossref
Crossref
Rosalind Gittins, Molly Howard, Ameer Ghodke, Timothy J Ives & Paul Chelminski. (2018) The Accuracy of a Fibromyalgia Diagnosis in General Practice. Pain Medicine 19:3, pages 491-498.
Crossref
Crossref
A. Yu. Elizarov. (2018) Mass Spectrometric Analysis of the Antinociceptive Effect of Lidocaine. Biophysics 62:6, pages 977-979.
Crossref
Crossref
Gillian R. Lauder. 2017. Pain Relief - From Analgesics to Alternative Therapies. Pain Relief - From Analgesics to Alternative Therapies.
Geoffrey Littlejohn & Emma Guymer. (2017) Modulation of NMDA Receptor Activity in Fibromyalgia. Biomedicines 5:4, pages 15.
Crossref
Crossref
Dermot P Maher, Lucy Chen & Jianren Mao. (2017) Intravenous Ketamine Infusions for Neuropathic Pain Management: A Promising Therapy in Need of Optimization. Anesthesia & Analgesia 124:2, pages 661-674.
Crossref
Crossref
Jared L. Pomeroy, Michael J. Marmura, Stephanie J. Nahas & Eugene R. Viscusi. (2017) Ketamine Infusions for Treatment Refractory Headache. Headache: The Journal of Head and Face Pain 57:2, pages 276-282.
Crossref
Crossref
Hiroshi Ueda & Hiroyuki Neyama. (2017) LPA1 receptor involvement in fibromyalgia-like pain induced by intermittent psychological stress, empathy. Neurobiology of Pain 1, pages 16-25.
Crossref
Crossref
Yasuo Itomi, Yasuhiro Tsukimi & Toru Kawamura. (2016) Impaired diffuse noxious inhibitory controls in specific alternation of rhythm in temperature-stressed rats. European Journal of Pharmacology 784, pages 61-68.
Crossref
Crossref
Geoffrey O Littlejohn, Emma K Guymer & Gene-Siew Ngian. (2016) Is there a role for opioids in the treatment of fibromyalgia?. Pain Management 6:4, pages 347-355.
Crossref
Crossref
Don L. Goldenberg, Daniel J. Clauw, Roy E. Palmer & Andrew G. Clair. (2016) Opioid Use in Fibromyalgia. Mayo Clinic Proceedings 91:5, pages 640-648.
Crossref
Crossref
Daniel Flack & Elias Dakwar. 2016. Neuropathology of Drug Addictions and Substance Misuse. Neuropathology of Drug Addictions and Substance Misuse
681
688
.
Nehan Munasinghe & MacDonald Christie. (2015) Conotoxins That Could Provide Analgesia through Voltage Gated Sodium Channel Inhibition. Toxins 7:12, pages 5386-5407.
Crossref
Crossref
Ernest H. S. Choy. (2015) The role of sleep in pain and fibromyalgia. Nature Reviews Rheumatology 11:9, pages 513-520.
Crossref
Crossref
Gary W. Jay & Robert L. Barkin. (2015) Fibromyalgia. Disease-a-Month 61:3, pages 66-111.
Crossref
Crossref
A. Morgan Kelly & Kimberly Mauer. 2015. Fibromyalgia. Fibromyalgia
103
112
.
Marni G. Hillinger & Ellen W. K. Rosenquist. 2015. Fibromyalgia. Fibromyalgia
165
174
.
Leonardo Ierardi Goulart, Raimundo Nonato Delgado Rodrigues & Mario Fernando Prieto Peres. (2014) Restless Legs Syndrome and Pain Disorders: What’s in common?. Current Pain and Headache Reports 18:11.
Crossref
Crossref
R. Stehlik, J. Ulfberg, J. Hedner & L. Grote. (2014) High prevalence of restless legs syndrome among women with multi-site pain: A population-based study in Dalarna, Sweden. European Journal of Pain 18:10, pages 1402-1409.
Crossref
Crossref
Per Hansson. (2014) Translational aspects of central sensitization induced by primary afferent activity: What it is and what it is not. Pain 155:10, pages 1932-1934.
Crossref
Crossref
R. Staud, E.E. Weyl, E. Bartley, D.D. Price & M.E. Robinson. (2014) Analgesic and anti-hyperalgesic effects of muscle injections with lidocaine or saline in patients with fibromyalgia syndrome. European Journal of Pain 18:6, pages 803-812.
Crossref
Crossref
Meredith C.B. Adams & Daniel Clauw. 2014. Practical Management of Pain. Practical Management of Pain
392
407.e3
.
Patrick Sichère. (2013) Le syndrome fibromyalgique : stratégies thérapeutiques. Douleurs : Evaluation - Diagnostic - Traitement 14:6, pages 292-301.
Crossref
Crossref
Susanne Becker, Marta Ceko, Mytsumi Louis-Foster, Nathaniel M. Elfassy, Marco Leyton, Yoram Shir & Petra Schweinhardt. (2013) Dopamine and Pain Sensitivity: Neither Sulpiride nor Acute Phenylalanine and Tyrosine Depletion Have Effects on Thermal Pain Sensations in Healthy Volunteers. PLoS ONE 8:11, pages e80766.
Crossref
Crossref
Sophie Logerot, Magalie Baudrant-Boga, Audrey Lehmann, Edith Schir, Anne Dumolard, Jean-Pierre Alibeu, Hassan Hodaj & Caroline-Maindet Dominici. (2013) Prise en charge ambulatoire des patients atteints de fibromyalgie par kétamine par voie sous-cutanée : que nous apprend la pratique ? Étude rétrospective observationnelle au CHU de Grenoble. Douleurs : Evaluation - Diagnostic - Traitement 14:2, pages 75-85.
Crossref
Crossref
Nicholas Fallon, Yee Ho Chiu, Xiaoyun Li, Turo J. Nurmikko & Andrej Stancak. (2013) Ipsilateral cortical activation in fibromyalgia patients during brushing correlates with symptom severity. Clinical Neurophysiology 124:1, pages 154-163.
Crossref
Crossref
Joseph F. Audette. 2013. Pain in Women. Pain in Women
59
93
.
Susanne Becker & Petra Schweinhardt. (2012) Dysfunctional Neurotransmitter Systems in Fibromyalgia, Their Role in Central Stress Circuitry and Pharmacological Actions on These Systems. Pain Research and Treatment 2012, pages 1-10.
Crossref
Crossref
Anne Estrup Olesen, Trine Andresen, Camilla Staahl & Asbjørn Mohr Drewes. (2012) Human Experimental Pain Models for Assessing the Therapeutic Efficacy of Analgesic Drugs. Pharmacological Reviews 64:3, pages 722-779.
Crossref
Crossref
Mats Persson, Jan Sörensen & Björn Gerdle. (2012) Whiplash Associated Disorders (WAD): Responses to pharmacological challenges and psychometric tests. Scandinavian Journal of Pain 3:3, pages 151-163.
Crossref
Crossref
C. Sommer, W. Häuser, R. Alten, F. Petzke, M. Späth, T. Tölle, N. Üçeyler, A. Winkelmann, E. Winter & K.J. Bär. (2012) Medikamentöse Therapie des FibromyalgiesyndromsDrug therapy of fibromyalgia syndrome. Der Schmerz 26:3, pages 297-310.
Crossref
Crossref
Dennis J. McCarthy, Robert Alexander, Mark A. Smith, Sanjeev Pathak, Stephen Kanes, Chi-Ming Lee & Gerard Sanacora. (2012) Glutamate-based depression GBD. Medical Hypotheses 78:5, pages 675-681.
Crossref
Crossref
Glenn T. Clark. 2012. Orofacial Pain. Orofacial Pain
271
294
.
Sheetal Patil & Magdalena Anitescu. (2012) Efficacy of Outpatient Ketamine Infusions in Refractory Chronic Pain Syndromes: A 5-Year Retrospective Analysis. Pain Medicine 13:2, pages 263-269.
Crossref
Crossref
Philip J. Mease, Kelly Dundon & Piercarlo Sarzi-Puttini. (2011) Pharmacotherapy of fibromyalgia. Best Practice & Research Clinical Rheumatology 25:2, pages 285-297.
Crossref
Crossref
Clifford J. Woolf. (2011) Central sensitization: Implications for the diagnosis and treatment of pain. Pain 152:3, pages S2-S15.
Crossref
Crossref
Gene-Siew NGIAN, Emma K. GUYMER & Geoffrey O. LITTLEJOHN. (2011) The use of opioids in fibromyalgia. International Journal of Rheumatic Diseases 14:1, pages 6-11.
Crossref
Crossref
&NA;. (2011) Treat the symptoms of fibromyalgia with a variety of strategies, as individual therapies provide only moderate benefits. Drugs & Therapy Perspectives 27:1, pages 17-20.
Crossref
Crossref
Michiko Nishiyori, Hitoshi Uchida, Jun Nagai, Kohei Araki, Takehiro Mukae, Shiroh Kishioka & Hiroshi Ueda. (2011) Permanent Relief from Intermittent Cold Stress-Induced Fibromyalgia-Like Abnormal Pain by Repeated Intrathecal Administration of Antidepressants. Molecular Pain 7, pages 1744-8069-7-69.
Crossref
Crossref
Richard J. Wurtman. (2010) Fibromyalgia and the complex regional pain syndrome: similarities in pathophysiology and treatment. Metabolism 59, pages S37-S40.
Crossref
Crossref
Ole Kudsk Jensen, Claus Vinther Nielsen & Kristian Stengaard‐Pedersen. (2012) Low back pain may be caused by disturbed pain regulation. European Journal of Pain 14:5, pages 514-522.
Crossref
Crossref
Michiko Nishiyori, Jun Nagai, Takahiro Nakazawa & Hiroshi Ueda. (2010) Absence of morphine analgesia and its underlying descending serotonergic activation in an experimental mouse model of fibromyalgia. Neuroscience Letters 472:3, pages 184-187.
Crossref
Crossref
Roland Staud. (2010) Pharmacological Treatment of Fibromyalgia Syndrome. Drugs 70:1, pages 1-14.
Crossref
Crossref
William S. Wilke, Abby Abelson & Ravindran Padmanabhan. 2010. Current Clinical Medicine. Current Clinical Medicine
1124
1128.e1
.
Robert J. Schwartzman, Guillermo M. Alexander, John R. Grothusen, Terry Paylor, Erin Reichenberger & Marielle Perreault. (2009) Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: A double-blind placebo controlled study. Pain 147:1, pages 107-115.
Crossref
Crossref
G.-H. E. TJAKKES, L. G. M. DE BONT, M. VAN WIJHE & B. STEGENGA. (2009) Classification of chronic orofacial pain using an intravenous diagnostic test. Journal of Oral Rehabilitation 36:7, pages 469-475.
Crossref
Crossref
Karin B. Jensen, Eva Kosek, Frank Petzke, Serena Carville, Peter Fransson, Hanke Marcus, Steven C.R. Williams, Ernest Choy, Thorsten Giesecke, Yves Mainguy, Richard Gracely & Martin Ingvar. (2009) Evidence of dysfunctional pain inhibition in Fibromyalgia reflected in rACC during provoked pain. Pain 144:1, pages 95-100.
Crossref
Crossref
Marcelo Derbli Schafranski, Tiago Malucelli, Fabíola Machado, Hélcio Takeshi, Flávia Kaiber, Carolina Schmidt & Fabielle Harth. (2009) Intravenous lidocaine for fibromyalgia syndrome: an open trial. Clinical Rheumatology 28:7, pages 853-855.
Crossref
Crossref
Lesley Arnold. 2009. Fibromyalgia. Fibromyalgia
56
80
.
Leslie Neal-Boylan. (2009) Update on Rheumatology: Part 1. Home Healthcare Nurse 27:5, pages 286-296.
Crossref
Crossref
Philip J. Mease & Ernest H. Choy. (2009) Pharmacotherapy of Fibromyalgia. Rheumatic Disease Clinics of North America 35:2, pages 359-372.
Crossref
Crossref
Patrick Sichère. (2009) Actualisation des thérapeutiques médicamenteuses dans le syndrome fibromyalgique. Douleurs : Evaluation - Diagnostic - Traitement 10:2, pages 84-89.
Crossref
Crossref
PATRICK B. WOOD & ANDREW J. HOLMAN. (2009) An Elephant Among Us: The Role of Dopamine in the Pathophysiology of Fibromyalgia. The Journal of Rheumatology 36:2, pages 221-224.
Crossref
Crossref
Philip J. Mease & Kristin Seymour. (2008) Fibromyalgia: Should the treatment paradigm be monotherapy or combination pharmacotherapy?. Current Pain and Headache Reports 12:6, pages 399-405.
Crossref
Crossref
Björn Gerdle, Nils Östlund, Christer Grönlund, Karin Roeleveld & J. Stefan Karlsson. (2008) Firing rate and conduction velocity of single motor units in the trapezius muscle in fibromyalgia patients and healthy controls. Journal of Electromyography and Kinesiology 18:5, pages 707-716.
Crossref
Crossref
C. Sommer, W. Häuser, M. Berliner, W. Brückle, S. Ehlers, K. Mönkemöller, B. Moradi, F. Petzke, N. Üçeyler, R. Wörz, E. Winter & D.O. Nutzinger. (2008) Medikamentöse Therapie des FibromyalgiesyndromsPharmacological treatment of fibromyalgia syndrome. Der Schmerz 22:3, pages 313-323.
Crossref
Crossref
. 2006. Wiley Handbook of Current and Emerging Drug Therapies. Wiley Handbook of Current and Emerging Drug Therapies.
Paola Sarchielli, Massimiliano Filippo, Katiuscia Nardi & Paolo Calabresi. (2007) Sensitization, glutamate, and the link between migraine and fibromyalgia. Current Pain and Headache Reports 11:5, pages 343-351.
Crossref
Crossref
Eric Guedj, Serge Cammilleri, Cecile Colavolpe, David Taieb, Catherine de Laforte, Jean Niboyet & Olivier Mundler. (2007) Predictive value of brain perfusion SPECT for ketamine response in hyperalgesic fibromyalgia. European Journal of Nuclear Medicine and Molecular Imaging 34:8, pages 1274-1279.
Crossref
Crossref
Lars Arendt Nielsen & Karl G. Henriksson. (2007) Pathophysiological mechanisms in chronic musculoskeletal pain (fibromyalgia): the role of central and peripheral sensitization and pain disinhibition. Best Practice & Research Clinical Rheumatology 21:3, pages 465-480.
Crossref
Crossref
Boris A. Chizh. (2016) Low dose ketamine: a therapeutic and research tool to explore N-methyl-D-aspartate (NMDA) receptor-mediated plasticity in pain pathways. Journal of Psychopharmacology 21:3, pages 259-271.
Crossref
Crossref
Patrick B. Wood, James C. PattersonIIII, John J. Sunderland, Kerrie H. Tainter, Michael F. Glabus & David L. Lilien. (2007) Reduced Presynaptic Dopamine Activity in Fibromyalgia Syndrome Demonstrated With Positron Emission Tomography: A Pilot Study. The Journal of Pain 8:1, pages 51-58.
Crossref
Crossref
E. Visser & S.A. Schug. (2006) The role of ketamine in pain management. Biomedicine & Pharmacotherapy 60:7, pages 341-348.
Crossref
Crossref
Steven P. Cohen, Michael H. Verdolin, Audrey S. Chang, Connie Kurihara, Bennie J. Morlando & Jianren Mao. (2006) The Intravenous Ketamine Test Predicts Subsequent Response to an Oral Dextromethorphan Treatment Regimen in Fibromyalgia Patients. The Journal of Pain 7:6, pages 391-398.
Crossref
Crossref
Timothy J. Ness & Alan Randich. (2006) Which Spinal Cutaneous Nociceptive Neurons Are Inhibited by Intravenous Lidocaine in the Rat?. Regional Anesthesia and Pain Medicine 31:3, pages 248-253.
Crossref
Crossref
MARK S. WALLACE, BRADLEY S. GALER & ARNOLD R. GAMMAITONI. 2006. Cancer Pain. Cancer Pain
327
335
.
Ivo W. Tremont-Lukats, Vidya Challapalli, Ewan D. McNicol, Joseph Lau & Daniel B. Carr. (2005) Systemic Administration of Local Anesthetics to Relieve Neuropathic Pain: A Systematic Review and Meta-Analysis. Anesthesia & Analgesia, pages 1738-1749.
Crossref
Crossref
Vidya Challapalli, Ivo W Tremont-Lukats, Ewan D McNicol, Joseph Lau & Daniel B Carr. (2005) Systemic administration of local anesthetic agents to relieve neuropathic pain. Cochrane Database of Systematic Reviews 2020:10.
Crossref
Crossref
Dag Lemming, Jan S??rensen, Thomas Graven-Nielsen, Lars Arendt-Nielsen & Bj??rn Gerdle. (2005) The Responses to Pharmacological Challenges and Experimental Pain in Patients With Chronic Whiplash-Associated Pain. The Clinical Journal of Pain 21:5, pages 412-421.
Crossref
Crossref
André Muller, Christian Rempp, Jacques Kopferschmitt, Marie-Thérèse Haeringer, Christian Brandt, Pierre Meyer, Jean-Louis Kuntz, Jean Sibilia & Jean-Marie Warter. (2005) Effets de la kétamine administrée par voie veineuse pendant trois jours sur les douleurs de fibromyalgie. Douleurs : Evaluation - Diagnostic - Traitement 6:3, pages 151-159.
Crossref
Crossref
Helen Slater, Lars Arendt-Nielsen, Anthony Wright & Thomas Graven-Nielsen. (2005) Sensory and motor effects of experimental muscle pain in patients with lateral epicondylalgia and controls with delayed onset muscle soreness. Pain 114:1, pages 118-130.
Crossref
Crossref
P.E. Baldry & John W. Thompson. 2005. Acupuncture, Trigger Points and Musculoskeletal Pain. Acupuncture, Trigger Points and Musculoskeletal Pain
127
148
.
M. Fall, A.P. Baranowski, C.J. Fowler, V. Lepinard, J.G. Malone-Lee, E.J. Messelink, F. Oberpenning, J.L. Osborne & S. Schumacher. (2004) EAU Guidelines on Chronic Pelvic Pain. European Urology 46:6, pages 681-689.
Crossref
Crossref
Randy A. Sansone & Robert Hawkins. (2004) Fibromyalgia, borderline personality, and opioid prescription. General Hospital Psychiatry 26:5, pages 415-416.
Crossref
Crossref
Rajan Radhakrishnan, Marie K. Hoeger Bement, David Skyba, Kathleen A. Sluka & Lois J. Kehl. (2004) Models of Muscle Pain: Carrageenan Model and Acidic Saline Model. Current Protocols in Pharmacology 25:1.
Crossref
Crossref
Wolfgang Koppert, Marc Weigand, Frank Neumann, Reinhard Sittl, J??rgen Schuettler, Martin Schmelz & Werner Hering. (2004) Perioperative Intravenous Lidocaine Has Preventive Effects on Postoperative Pain and Morphine Consumption After Major Abdominal Surgery. Anesthesia & Analgesia, pages 1050-1055.
Crossref
Crossref
Mark W Douglas, Robert W Johnson & Anthony L Cunningham. (2004) Tolerability of Treatments for Postherpetic Neuralgia. Drug Safety 27:15, pages 1217-1233.
Crossref
Crossref
Graham Hocking & Michael J. Cousins. (2003) Ketamine in Chronic Pain Management: An Evidence-Based Review. Anesthesia & Analgesia 97:6, pages 1730-1739.
Crossref
Crossref
Karl G. Henriksson. (2003) Hypersensitivity in muscle pain syndromes. Current Pain and Headache Reports 7:6, pages 426-432.
Crossref
Crossref
Martin L Pall. (2003) Elevated nitric oxide/peroxynitrite theory of multiple chemical sensitivity: central role of N-methyl-D-aspartate receptors in the sensitivity mechanism.. Environmental Health Perspectives 111:12, pages 1461-1464.
Crossref
Crossref
H. Schulte, T. Graven-Nielsen, A. Sollevi, Y. Jansson, L. Arendt-Nielsen & M. Segerdahl. (2003) Pharmacological modulation of experimental phasic and tonic muscle pain by morphine, alfentanil and ketamine in healthy volunteers. Acta Anaesthesiologica Scandinavica 47:8, pages 1020-1030.
Crossref
Crossref
Eric S. Hsu. (2003) Myofascial pain syndrome and fibromyalgia. Seminars in Anesthesia, Perioperative Medicine and Pain 22:3, pages 152-158.
Crossref
Crossref
A. Kvarnström, R. Karlsten, H. Quiding, B.-M. Emanuelsson & T. Gordh. (2003) The effectiveness of intravenous ketamine and lidocaine on peripheral neuropathic pain. Acta Anaesthesiologica Scandinavica 47:7, pages 868-877.
Crossref
Crossref
Srinivas G Rao & Robert M Bennett. (2003) Pharmacological therapies in fibromyalgia. Best Practice & Research Clinical Rheumatology 17:4, pages 611-627.
Crossref
Crossref
C Chan Gunn, Rajesh Munglani & Andreas Erdmann. 2003. Pain. Pain.
Serge Perrot. (2003) Des médicaments pour traiter la fibromyalgie ?. Revue du Rhumatisme 70:4, pages 340-345.
Crossref
Crossref
JH Raphael, JL Southall, GJ Treharne & GD Kitas. (2002) Efficacy and adverse effects of intravenous lignocaine therapy in fibromyalgia syndrome. BMC Musculoskeletal Disorders 3:1.
Crossref
Crossref
Donald D. Price, Roland Staud, Michael E. Robinson, Andre P. Mauderli, Richard Cannon & Charles J. Vierck. (2002) Enhanced temporal summation of second pain and its central modulation in fibromyalgia patients. Pain 99:1, pages 49-59.
Crossref
Crossref
D. A. Skyba, E. W. King & K. A. Sluka. (2002) Effects of NMDA and non-NMDA ionotropic glutamate receptor antagonists on the development and maintenance of hyperalgesia induced by repeated intramuscular injection of acidic saline. Pain 98:1, pages 69-78.
Crossref
Crossref
Robert M Bennett. (2002) The rational management of fibromyalgia patients. Rheumatic Disease Clinics of North America 28:2, pages 181-199.
Crossref
Crossref
Karl G Henriksson & Jan Sörensen. (2002) The promise of N-methyl-d-aspartate receptor antagonists in fibromyalgia. Rheumatic Disease Clinics of North America 28:2, pages 343-351.
Crossref
Crossref
André Barkhuizen. (2002) Rational and targeted pharmacologic treatment of fibromyalgia. Rheumatic Disease Clinics of North America 28:2, pages 261-290.
Crossref
Crossref
Srinivas G Rao. (2002) The neuropharmacology of centrally-acting analgesic medications in fibromyalgia. Rheumatic Disease Clinics of North America 28:2, pages 235-259.
Crossref
Crossref
SIV SÖDERBERG, BERIT LUNDMAN & ASTRID NORBERG. (2002) The meaning of fatigue and tiredness as narrated by women with fibromyalgia and healthy women. Journal of Clinical Nursing 11:2, pages 247-255.
Crossref
Crossref
Karin ??. Forseth & Jan T. Gran. (2002) Management of Fibromyalgia. Drugs 62:4, pages 577-592.
Crossref
Crossref
Muhammad B. Yunus & Fatma inanici. 2002. Myofascial Pain and Fibromyalgia. Myofascial Pain and Fibromyalgia
3
31
.
P. Walger. 2002. (S)-Ketamin. (S)-Ketamin
17
46
.
Dan Buskila & Joseph Press. (2001) Neuroendocrine mechanisms in fibromyalgia–chronic fatigue. Best Practice & Research Clinical Rheumatology 15:5, pages 747-758.
Crossref
Crossref
Rinie Geenen & Johannes W.G. Jacobs. (2001) Fibromyalgia: diagnosis, pathogenesis, and treatment. Current Opinion in Anaesthesiology 14:5, pages 533-539.
Crossref
Crossref
J Eisinger. (2001) Fibromyalgie : non-entité ou agent double ?. La Revue de Médecine Interne 22:9, pages 809-811.
Crossref
Crossref
M.L. Pall. (2001) Common etiology of posttraumatic stress disorder, fibromyalgia, chronic fatigue syndrome and multiple chemical sensitivity via elevated nitric oxide/peroxynitrite. Medical Hypotheses 57:2, pages 139-145.
Crossref
Crossref
André Barkhuizen. (2001) Pharmacologic treatment of fibromyalgia. Current Pain and Headache Reports 5:4, pages 351-358.
Crossref
Crossref
Daniel J. Clauw. (2006) Potential Mechanisms in Chemical Intolerance and Related Conditions. Annals of the New York Academy of Sciences 933:1, pages 235-253.
Crossref
Crossref
Dirk van West & Michael Maes. (2001) Neuroendocrine and Immune Aspects of Fibromyalgia. BioDrugs 15:8, pages 521-531.
Crossref
Crossref
Marian E. Fundytus. (2001) Glutamate Receptors and Nociception. CNS Drugs 15:1, pages 29-58.
Crossref
Crossref
Kim Fisher, Terence J Coderre & Neil A Hagen. (2000) Targeting the N-Methyl-d-Aspartate Receptor for Chronic Pain Management. Journal of Pain and Symptom Management 20:5, pages 358-373.
Crossref
Crossref
Karin L. Petersen & Michael C. Rowbotham. (2000) Will ion-channel blockers be useful for management of nonneuropathic pain?. The Journal of Pain 1:3, pages 26-34.
Crossref
Crossref
L Bendtsen. (2016) Central Sensitization in Tension-Type Headache—Possible Pathophysiological Mechanisms. Cephalalgia 20:5, pages 486-508.
Crossref
Crossref
Thomas Graven-Nielsen, Sally Aspegren Kendall, Karl G. Henriksson, Mats Bengtsson, Jan Sörensen, Anders Johnson, Björn Gerdle & Lars Arendt-Nielsen. (2000) Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients. Pain 85:3, pages 483-491.
Crossref
Crossref
Wolfgang Koppert, Nikola Ostermeier, Reinhard Sittl, Christian Weidner & Martin Schmelz. (2000) Low-dose lidocaine reduces secondary hyperalgesia by a central mode of action. Pain 85:1, pages 217-224.
Crossref
Crossref
Jane H. Park, Kenneth J. Niermann & Nancy J. Olsen. (2000) Evidence for metabolic abnormalities in the muscles of patients with fibromyalgia. Current Rheumatology Reports 2:2, pages 131-140.
Crossref
Crossref
Prem Bajaj, Thomas Graven-Nielsen, Anthony Wright, lolo ab Ithel Davies & Lars Arendt-Nielsen. (2000) Muscle hyperalgesia in postexercise muscle soreness assessed by single and repetitive ultrasound stimuli. The Journal of Pain 1:2, pages 111-121.
Crossref
Crossref
Mona Koelbaek Johansen, Thomas Graven-Nielsen, Anders Schou Olesen & Lars Arendt-Nielsen. (1999) Generalised muscular hyperalgesia in chronic whiplash syndrome. Pain 83:2, pages 229-234.
Crossref
Crossref
Dan Buskila. (1999) Drug therapy. Best Practice & Research Clinical Rheumatology 13:3, pages 479-485.
Crossref
Crossref
Kim Fisher & Neil A Hagen. (1999) Analgesic Effect of Oral Ketamine in Chronic Neuropathic Pain of Spinal Origin. Journal of Pain and Symptom Management 18:1, pages 61-66.
Crossref
Crossref
Robert M. Bennett. (1999) Emerging Concepts in the Neurobiology of Chronic Pain: Evidence of Abnormal Sensory Processing in Fibromyalgia. Mayo Clinic Proceedings 74:4, pages 385-398.
Crossref
Crossref
Sidney R. Block. (1999) On the nature of rheumatism. Arthritis & Rheumatism 12:2, pages 129-138.
Crossref
Crossref
Michael J. Hudspith & Rajesh Munglani. (2012) Neuropeptide Y: Friend or foe?. European Journal of Pain 3:1, pages 3-6.
Crossref
Crossref
John B. Winfield. (1999) PAIN IN FIBROMYALGIA. Rheumatic Disease Clinics of North America 25:1, pages 55-79.
Crossref
Crossref
S. ARNÉR. (1998) Pain analysis in prediction of treatment outcome. Acta Anaesthesiologica Scandinavica 42, pages 24-28.
Crossref
Crossref
GRACIELA S. ALARCÓN & LAURENCE A. BRADLEY. (1998) Advances in the Treatment of Fibromyalgia: Current Status and Future Directions. The American Journal of the Medical Sciences 315:6, pages 397-404.
Crossref
Crossref
M. Andersson, J.R. Bagby, L.‐E. Dyrehag & C.‐G. Gottfries. (2012) Effects of staphylococcus toxoid vaccine on pain and fatigue in patients with fibromyalgia/chronic fatigue syndrome. European Journal of Pain 2:2, pages 133-142.
Crossref
Crossref
E. Kalso, M.R. Tramèr, H.J. McQuay & R.A. Moore. (2012) Systemic local‐anaesthetic‐type drugs in chronic pain: A systematic review. European Journal of Pain 2:1, pages 3-14.
Crossref
Crossref
M Bergenheim, A.G Crenshaw, J Pedersen & H Johansson. (1998) The information transmitted by ensembles of primary spindle afferents is diminished when ketamine is used as a pre-anaesthetic. Neuroscience Research 30:2, pages 177-183.
Crossref
Crossref
Lars Arendt-Nielsen, Thomas Graven-Nielsen, Peter Svensson & Troels S. Jensen. (1997) Temporal summation in muscles and referred pain areas: An experimental human study. Muscle & Nerve 20:10, pages 1311-1313.
Crossref
Crossref
R. Bennett. (2016) Review : The concurrence of lupus and fibromyalgia: implications for diagnosis and management. Lupus 6:6, pages 494-499.
Crossref
Crossref
K.G. Henriksson. (2012) MECHANISMS AND CLINICAL ASPECTS OF MUSCLE PAIN. European Journal of Pain 1:1, pages 69-70.
Crossref
Crossref
Robert M. Bennett. (2005) Fibromyalgia and the disability dilemma. A new era in understanding a complex, multidimensional pain syndrome. Arthritis & Rheumatism 39:10, pages 1627-1634.
Crossref
Crossref